About Piomic
Piomic is a company based in Zurich (Switzerland) founded in 2016 by Jurg Frohlich, Christopher Hertz, Jari Kruth, and Marc Augsburger. Piomic has raised $7.83 million across 3 funding rounds from investors including Zurcher Kantonalbank, European Union and Diabetes Venture Fund. Piomic operates in a competitive market with competitors including Sky Medical Technology, Celleration, Intelligent Implants, Vomaris Innovations and Biofisica, among others.
- Headquarter Zurich, Switzerland
- Founders Jurg Frohlich, Christopher Hertz, Jari Kruth, Marc Augsburger
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Piomic Medical Ag
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.83 M (USD)
in 3 rounds
-
Latest Funding Round
$7.83 M (USD), Series A
Jul 29, 2022
-
Investors
Zurcher Kantonalbank
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Piomic
Unlock access to complete
Unlock access to complete
Funding Insights of Piomic
Piomic has successfully raised a total of $7.83M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $7.83 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Piomic
Piomic has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Zurcher Kantonalbank, European Union and Diabetes Venture Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on diabetes technology startups worldwide.
|
Locked | Locked | Locked | |
|
Venture capital firm focused on science and tech-driven startups
|
Locked | Locked | Locked | |
|
Commercial banking services are provided across Switzerland by Zurcher Kantonalbank.
|
Locked | Locked | Locked |
Investor details for Piomic
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Piomic
Investment portfolio details for Piomic
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Piomic
Detailed financials for Piomic
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Piomic Comparisons
Peer comparison for Piomic
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Piomic
Piomic operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sky Medical Technology, Celleration, Intelligent Implants, Vomaris Innovations and Biofisica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
Ultrasound technology for wound healing is developed and marketed.
|
|
| Locked | Locked | Locked |
Develops smart implants to accelerate and monitor bone growth in orthopedics.
|
|
| Locked | Locked | Locked |
Bio-mimicking microcurrent technology is applied to wound healing.
|
|
| Locked | Locked | Locked |
Develops electrical stimulation devices to promote wound healing.
|
Detailed competitors of Piomic
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Piomic
Complete news archive for Piomic
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Piomic
Piomic was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Piomic is headquartered in Zurich, Switzerland.
Christopher Hertz is the current CEO of Piomic. They have also founded this company.
Piomic is a funded company, having raised a total of $7.83M across 3 funding rounds to date.
Piomic was established in 2016 in Zurich, Switzerland, within the medical technology sector. Focus is placed on developing a non-invasive electroceutical device aimed at treating chronic wounds. The device is intended to support wound healing, manage pain and inflammation, and contribute to better clinical results. Operations center on electroceutical innovations for healthcare applications in Europe.
Piomic's top competitors include Sky Medical Technology, BioElectronics Corporation and Celleration.
Piomic has 5 investors. Key investors include Zurcher Kantonalbank, European Union, Diabetes Venture Fund, Verve Ventures, and Nest Sammelstiftung.